Drug Shortage Report for MAR-ROSUVASTATIN
| Report ID | 224359 |
| Drug Identification Number | 02413108 |
| Brand name | MAR-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-05 |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-04-06 | English | Compare |
| v2 | 2024-04-05 | French | Compare |
| v1 | 2024-04-05 | English | Compare |
Showing 1 to 3 of 3